[Treatment of cytostatic-induced hyperuricaemia with allopurinol (author's transl)].
D000230:Adenocarcinoma / Q000188:drug therapy; D000493:Allopurinol / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D001984:Bronchial Neoplasms / Q000188:drug therapy; D005260:Female; D006073:Gout / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D010954:Plasmacytoma / Q000188:drug therapy; D012509:Sarcoma / Q000188:drug therapy; D014527:Uric Acid / Q000097:blood
D000970:Antineoplastic Agents; D014527:Uric Acid; D000493:Allopurinol
Allopurinolbehandlung der zytostatikainduzierten Hyperurikämie.